Updated daily
# | PubMedId | Deleted | Publication |
---|---|---|---|
38170575 | 0 | Sultan N, Pelland-Marcotte MC, Remy M, et al. Real-world data of the use of rivaroxaban in pediatric patients with hematologic malignancies. Leuk Lymphoma. 2024 Apr;65(4):538-540. doi: 10.1080/10428194.2023.2300719. Epub 2024 Jan 3. | |
38164978 | 0 | Pelland-Marcotte MC, Kulkarni K, Tran TH, et al. Risk factors and clinical impact of thrombosis during induction chemotherapy for pediatric acute lymphoblastic leukemia: A report from CYP-C. Am J Hematol. 2024 Jan 2. doi: 10.1002/ajh.27171. | |
37594628 | 0 | Pelland-Marcotte MC, Stavrakoukas A, Wong G, et al. French Canadian cross-cultural adaptation of CAPTSure(c), an index for the Clinical Assessment of Post-Thrombotic Syndrome in children. J Patient Rep Outcomes. 2023 Aug 18;7(1):83. doi: 10.1186/s41687-023-00622-7. | |
37287631 | 0 | El Maamari J, Amid A, Pelland-Marcotte MC, et al. Between Scylla and Charybdis: thrombosis in children with hemophilia. Front Pediatr. 2023 May 23;11:1173549. doi: 10.3389/fped.2023.1173549. eCollection 2023. | |
36958517 | 0 | Pelland-Marcotte MC, Bouchard V, Begin E, et al. Biomarkers in pediatric venous thromboembolism: a systematic review of the literature. J Thromb Haemost. 2023 Mar 21:S1538-7836(23)00242-8. doi: 10.1016/j.jtha.2023.03.012. | |
36427068 | 0 | Pelland-Marcotte MC, Tole S, Bouhelier E, et al. Rivaroxaban for Management of Venous Thromboembolism in Pediatric Nephrotic Syndrome; a Case Report and Review of Literature. Pediatr Hematol Oncol. 2022 Nov 25:1-8. doi: 10.1080/08880018.2022.2150797. | |
36326142 | 0 | Zabeida A, Winikoff R, Pelland-Marcotte MC, et al. COVID-19-associated coagulopathy in children: A multicenter observational cohort study. Pediatr Blood Cancer. 2022 Nov 3:e30079. doi: 10.1002/pbc.30079. | |
33848369 | 0 | Pelland-Marcotte MC, Kulkarni K, Athale UH, et al. Thrombosis is associated with worse survival in children with acute lymphoblastic leukemia: A report from CYP-C. Am J Hematol. 2021 Jul 1;96(7):796-804. doi: 10.1002/ajh.26193. Epub 2021 May 10. | |
33231123 | 0 | Lemieux-Sarrasin D, Pelland-Marcotte MC, Simonyan D, et al. Distance to the pediatric oncology center does not affect survival in children with acute lymphoblastic leukemia: a report from CYP-C. Leuk Lymphoma. 2021 Apr;62(4):960-966. doi: 10.1080/10428194.2020.1849673. Epub 2020 Nov 24. | |
32557627 | 0 | Pelland-Marcotte MC, Amiri N, Avila ML, et al. Low molecular weight heparin for prevention of central venous catheter-related thrombosis in children. Cochrane Database Syst Rev. 2020 Jun 18;6:CD005982. doi: 10.1002/14651858.CD005982.pub3. | |
31600808 | 0 | Pelland-Marcotte MC, Tole S, Pechlivanoglou P, et al. Effectiveness and Safety of Primary Thromboprophylaxis in Children with Cancer: A Systematic Review of the Literature and Network Meta-Analysis. Thromb Haemost. 2019 Dec;119(12):2034-2042. doi: 10.1055/s-0039-1697027. Epub 2019 Oct 10. | |
31030810 | 0 | Pelland-Marcotte MC, Carcao MD. Hemophilia in a Changing Treatment Landscape. Hematol Oncol Clin North Am. 2019 Jun;33(3):409-423. doi: 10.1016/j.hoc.2019.01.007. Epub 2019 Mar 29. | |
30772417 | 0 | Pelland-Marcotte MC, Tucker C, Klaassen A, et al. Outcomes and risk factors of massive and submassive pulmonary embolism in children: a retrospective cohort study. Lancet Haematol. 2019 Mar;6(3):e144-e153. doi: 10.1016/S2352-3026(18)30224-2. Epub 2019 Feb 13. | |
30141279 | 0 | Pelland-Marcotte MC, Humpl T, James PD, et al. Idiopathic pulmonary arterial hypertension - a unrecognized cause of high-shear high-flow haemostatic defects (otherwise referred to as acquired von Willebrand syndrome) in children. Br J Haematol. 2018 Oct;183(2):267-275. doi: 10.1111/bjh.15530. Epub 2018 Aug 23. |